Biological E Vaccine
-
{
- All
- News
- Videos
-
India Set To Get Dengue Vaccine Qdenga Soon: Doctors Explain What To Expect
India is set to get a dengue vaccine named Qdenga to tackle the disease burden that it poses. Dr Rashmi Khadapkar and Dr Neha Rastogi explain what people can expect from this announcement.
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine has received approval for manufacture and commercialisation in India.
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Corbevax Cleared As Covid Booster Shot For Those 18 And Above
Biological E's COVID-19 vaccine Corbevax has been cleared for booster shot for those 18 and above.
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
-
"Most Affordable": Biological E Chief On Kids' Vaccine Corbevax
Mahima Datla, the MD of Biological E -- whose vaccine Corbevax was launched today for 12-to 14-year-olds in the country -- today indicated that the affordability of her vaccine was one of the key goals they worked for.
-
India's 'Vaccine Woman' On Corbevax Rolled Out For Children: Highlights
Mahima Datla, Managing Director of Biological E Ltd., is speaking to NDTV as India today started the vaccination of children aged 12 to 14 years.
-
Corbevax For Children To Cost Rs 800 In Market, Rs 145 For Government
The Corbevax COVID-19 vaccine for those aged 12 to 14 will cost Rs 800 in the market before taxes, sources have said. It will be sold to the government at Rs 145, the lowest in the world.
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
-
Biological E's Corbevax Gets Expert Panel's Approval For Teens: Report
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
-
Quad-Supported Vaccine, Manufactured By India, To Roll Out In First Half
The first batch of COVID-19 vaccines that are part of the Quad group of countries' pledge to donate shots across the world, manufactured by India's Biological E, will roll out in the first half of 2022, the grouping said in a statement on Friday.
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
-
Texas-India Vaccine Diplomacy Announces Covid Vaccine For $1.5 Per Dose
The Texas-India vaccine diplomacy, a collaboration for shared global health between Indian pharmaceutical company Biological E and the Texas Children''s Hospital and Baylor College of Medicine, has led to the development of a cost-efficient vaccine
-
India Set To Get Dengue Vaccine Qdenga Soon: Doctors Explain What To Expect
India is set to get a dengue vaccine named Qdenga to tackle the disease burden that it poses. Dr Rashmi Khadapkar and Dr Neha Rastogi explain what people can expect from this announcement.
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine has received approval for manufacture and commercialisation in India.
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Corbevax Cleared As Covid Booster Shot For Those 18 And Above
Biological E's COVID-19 vaccine Corbevax has been cleared for booster shot for those 18 and above.
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
-
"Most Affordable": Biological E Chief On Kids' Vaccine Corbevax
Mahima Datla, the MD of Biological E -- whose vaccine Corbevax was launched today for 12-to 14-year-olds in the country -- today indicated that the affordability of her vaccine was one of the key goals they worked for.
-
India's 'Vaccine Woman' On Corbevax Rolled Out For Children: Highlights
Mahima Datla, Managing Director of Biological E Ltd., is speaking to NDTV as India today started the vaccination of children aged 12 to 14 years.
-
Corbevax For Children To Cost Rs 800 In Market, Rs 145 For Government
The Corbevax COVID-19 vaccine for those aged 12 to 14 will cost Rs 800 in the market before taxes, sources have said. It will be sold to the government at Rs 145, the lowest in the world.
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
-
Biological E's Corbevax Gets Expert Panel's Approval For Teens: Report
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
-
Quad-Supported Vaccine, Manufactured By India, To Roll Out In First Half
The first batch of COVID-19 vaccines that are part of the Quad group of countries' pledge to donate shots across the world, manufactured by India's Biological E, will roll out in the first half of 2022, the grouping said in a statement on Friday.
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
-
Texas-India Vaccine Diplomacy Announces Covid Vaccine For $1.5 Per Dose
The Texas-India vaccine diplomacy, a collaboration for shared global health between Indian pharmaceutical company Biological E and the Texas Children''s Hospital and Baylor College of Medicine, has led to the development of a cost-efficient vaccine
